BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Georgetown University Release: Study Shows Weight Loss And Decreased Food Cravings With Phase 2 White Kidney Bean Extract


12/3/2013 10:58:25 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

KEARNY, NJ--(Marketwired - December 03, 2013) -

Obesity, the official peer-reviewed research journal of The Obesity Society, has published the largest weight loss and weight management clinical study, to date, on Phase 2 white kidney bean extract, an all-natural, non-stimulant proprietary ingredient found in many carbohydrate blocking nutritional supplements.

In the double-blind study, 123 participants were randomly selected to take Phase 2 white kidney bean extract or a placebo. Participants taking Phase 2 lost an average of 7 pounds at the conclusion of 12 weeks and lost significantly more body fat mass and weight circumference compared to the placebo group. Additionally, 73.5 percent of participants maintained their body weight after 24 weeks and reported decreased desire in sugary food cravings compared to the placebo group, which reported a significant increase in craving sweets. The study is the longest single clinical study conducted on Phase 2 and the first to show benefits from weight management in addition to weight loss.

"This study completely validates a dozen previous Phase 2 studies conducted in the past decade," said Dr. Harry Preuss, a Georgetown University professor in the Departments of Biochemistry, Medicine and Pathology. "This study is unique since most clinical trials don't follow participants for this length of time. The decrease in desire for sweets and increase in overall happiness with participants taking Phase 2 is very interesting data and confirms what we have believed was possible with this specific white kidney bean extract."

Dr. Preuss says the study, conducted in Berlin, was well designed and considered the gold standard of European studies. The weight management portion shows Phase 2 doesn't stop working over time but becomes more effective the longer it is used.

Lead researchers of the study confirm that reduction in body weight from participants using Phase 2 was due to loss of fat mass, not muscle. Improvement in body composition was also documented.

Phase 2 is the only white kidney bean extract backed by numerous clinical studies for efficacy and can be found in nutritional supplements including: Natrol's Carb Intercept, Now Foods' Starch Neutralizer, Swanson's Phase 2 Starch Neutralizer and GNC's Total Lean Phase 2 Carb Controller. For more information, visit: www.phase2info.com.


Media Contact:
Amy Summers
917-344-9741
Email Contact
Pitch Publicity

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES